Controlled release of injectable liposomal in situ gel loaded with recombinant human bone morphogenetic protein-2 for the repair of alveolar bone clefts in rabbits

References

• Burnham JM, Shults J, Petit MA, et al. (2007). Alterations in proximal femur geometry in children treated with glucocorticoids for Crohn disease or nephrotic syndrome: impact of the underlying disease. J Bone Miner Res 22:551–9
   PubMed Web of Science ®Google Scholar
• Choudhari KB, Labhasetwar V, Dorle AK. (1994). Liposomes as a carrier for oral administration of insulin: effect of formulation factors. J Microencapsul 11:319–25
   PubMed Web of Science ®Google Scholar
• Doijad RC, Manvi FV, Malleswara Rao V, Alase P. (2006). Sustained ophthalmic delivery of gatifloxacin from in situ gelling system. Indian J Pharm Sci 68:814–18
   Google Scholar
• Evans CA. (2004). Orthodontic treatment for patients with clefts. Clin Plast Surg 31:271–90
   PubMed Web of Science ®Google Scholar
• Falcini F, Trapani S, Civinini R, et al. (1996). The primary role of steroids on the osteoporosis in juvenile rheumatoid patients evaluated by dual energy X-ray absorptiometry. J Endocrinol Invest 19:165–9
   PubMed Web of Science ®Google Scholar
• Foradada M, Estelrich J. (1995). Encapsulation of thioguanine in liposomes. Int J Pharm 24:261–9
   Web of Science ®Google Scholar
• Geiger M, Li RH, Friess W. (2003). Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55:1613–29
   PubMed Web of Science ®Google Scholar
• Gilbert JC, Richardson JL, Davis MC, et al. (1987). The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J Control Release 5:113–18
   Google Scholar
• Gimbel M, Ashley RK, Sisodia M, et al. (2007). Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix. J Craniofac Surg 18:895–901
   PubMed Web of Science ®Google Scholar
• Gulati M, Grover M, Singh M, Singh S. (1998). Study of azathioprine encapsulation into liposomes. J Microencapsul 15:485–94
   PubMed Web of Science ®Google Scholar
• Haidar ZS, Hamdy RC, Tabrizian M. (2009). Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 31:1825–35
   PubMed Web of Science ®Google Scholar
• Hassan AH, Al-Hubail A, Al-Fraidi AA. (2010). Bone inductive proteins to enhance postorthodontic stability. Angle Orthod 80:1051–60
   PubMed Web of Science ®Google Scholar
• Hassan AH, Evans CA, Zaki AM, George A. (2003). Use of bone morphogenetic protein-2 and dentin matrix protein-1 to enhance the osteointegration of the Onplant system. Connect Tissue Res 44:30–41
   PubMed Web of Science ®Google Scholar
• Hatefi A, Amesden B. (2002). Biodegradable injectable in-situ forming drug delivery systems. J Control Release 80:9–28
   PubMed Web of Science ®Google Scholar
• Herford AS, Boyne P J. (2008). Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66:6166–75
   Google Scholar
• Hibi H, Yamada Y, Ueda M, Endo Y. (2006). Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg 35:551–5
   PubMed Web of Science ®Google Scholar
• Hosny KM. (2009a). Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin. AAPS PharmSciTech 10:1336–42
   PubMed Web of Science ®Google Scholar
• Hosny KM. (2009b). Ciprofloxacin as ocular liposomal hydrogel. AAPS Pharmacscitech 2:241–6
   Google Scholar
• Hosny KM, Banjar ZM. (2013). The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin Drug Deliv 10:1033–41
   PubMed Web of Science ®Google Scholar
• Jansson B, Hägerström H, Fransén N, et al. (2005). The influence of gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivo. Eur J Pharm Biopharm 59:557–64
   PubMed Web of Science ®Google Scholar
• Kashyap N, Viswanad B, Sharma G, et al. (2007). Design and evaluation of biodegradable, biosensitive in situ gelling systems for pulsatile delivery of insulin. Biomaterials 28:2051–60
   PubMed Web of Science ®Google Scholar
• Keller BC. (2001). Liposomes in nutrition. Trends Food Sci Technol 12: 25–31
   Web of Science ®Google Scholar
• Lasic DD, ed. (1993). Preparation of liposomes. In: Liposomes: from physics to application. Amsterdam, The Netherlands: Elsevier Science Publisher B.V.; 1993:63–107
   Google Scholar
• Mori M, Isobe M, Yamazaki Y, et al. (2000). Restoration of segmental bone defects in rabbit radius by biodegradable capsules containing recombinant human bone morphogenetic protein-2. J Biomed Mater Res 50:191–8
   PubMed Web of Science ®Google Scholar
• New RC. (1990). Liposomes: a practical approach. Oxford: Oxford University Press
   Google Scholar
• Nii T, Ishii F. (2005). Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198–205
   PubMed Web of Science ®Google Scholar
• Perugini P, Pavanetto F. (1998). Liposomes containing boronophenylalanine for boron neutron capture therapy. J Microencapsul 15:473–83
   PubMed Web of Science ®Google Scholar
• Puumanen K, Kellomäki M, Ritsilä V, et al. (2005). A novel bioabsorbable composite membrane of polyactive 70/30 and bioactive glass number 13–93 in repair of experimental maxillary alveolar cleft defects. J Biomed Mater Res B Appl Biomater 75:25–33
   PubMed Web of Science ®Google Scholar
• Rodriguez S, Allémann E, Fessi H, Doelker E. (2004). Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 21:1428–39
   PubMed Web of Science ®Google Scholar
• Saito N, Okada T, Horiuchi H, et al. (2001). A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 19:332–5
   PubMed Web of Science ®Google Scholar
• Sawada Y, Hokugo A, Yangm Y, et al. (2009). A trial of alveolar cleft bone regeneration by controlled release of bone morphogenetic protein: an experimental study in rabbits. Oral Maxillofac Surg 108:812–20
   Web of Science ®Google Scholar
• Sulkowski WW, Pentak D, Nowak K, Sułkowska A. (2005). The influence of temperature, cholesterol content and pH on liposome stability. J Mol Struct 744:737–47
   Web of Science ®Google Scholar
• Swan MC, Goodacre TE. (2006). Morbidity at the iliac crest donor site following bone grafting of the cleft alveolus. Br J Oral Maxillofac Surg 44:129–33
   PubMed Web of Science ®Google Scholar
• Szoka F, Papahodjopoulos D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75:4194–8
   PubMed Web of Science ®Google Scholar
• Urist MR, Lietze A, Dawson E. (1984). Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop Relat Res 177:277–80
   Google Scholar
• Xia SQ, Xu SY. (2005). Ferrous sulfate liposomes: preparation, stability and application in fluid milk. Food Res Int 38:289–96
   Web of Science ®Google Scholar
• Yamamoto M, Takahashi Y, Tabata Y. (2006). Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12:1305–11
   PubMedGoogle Scholar
• Zegzula HD, Buck DC, Brekke J, et al. (1997). Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 79:1778–90
   PubMed Web of Science ®Google Scholar